FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: OCTOBER 24, 2021

Results 1 through 18 of 18

IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES - SIC # 2835

Ticker Exchange Company Financial Reports SIC #
ABMC Over the counter American Bio Medica Corporatio 2835
AWH Nasdaq Aspira Womens Health Inc 2835
CDMO Nasdaq Avid Bioservices Inc 2835
CEMI Nasdaq Chembio Diagnostics Inc 2835
CYTR Over the counter CytRx Corporation 2835
GH Nasdaq Guardant Health Inc 2835
LHDX Nasdaq Lucira Health Inc 2835
MODD Over the counter Modular Medical Inc 2835
MYGN Nasdaq Myriad Genetics, Inc. 2835
NEOG Nasdaq Neogen Corporation 2835
NTRA Nasdaq Natera Inc 2835
OCDX Nasdaq Ortho Clinical Diagnostics Hol 2835
OSUR Nasdaq OraSure Technologies, Inc. 2835
QDEL Nasdaq Quidel Corporation 2835
QTXB Over the counter Quantrx Biomedical Corporation 2835
SMFR Nasdaq Sema4 Holdings Corp 2835
TKNO Nasdaq Alpha Teknova Inc 2835
TRIB Nasdaq Trinity Biotech plc (ADR) 2835
Results 0 through 18 of 18